Both copyright and Semaglutide represent a category of drugs called Glucagon-like Peptide-1 GLP-1 stimulators. These powerful treatments operate by mimicking the body's own chemical , Glucagon-like Peptide-1, to help lower blood sugar and encourage weight reduction . This shared mechanism of action demonstrates why such treatments are commonly cons